EMA reviews anti-hair loss products

EMA reviews anti hair loss products
share-arrowShare

unsaveSave

expand-left

full screen Medicines for, among other things, hair loss are suspected of leading to suicidal thoughts by the European Medicines Agency EMA, which has started an investigation. Archive image. Photo: Peter Dejong/AP/TT

The European Medicines Agency (EMA) has started a review of two medicines that are used, among other things, against hair loss, the Swedish Medicines Agency states in a press release.

The reason is that suicidal thoughts and self-harming behavior are suspected to be possible side effects of the drugs.

Psychiatric side effects, such as depression, are already known risks for the drugs.

afbl-general-01